Evidence map›Paper›PMID 39928254›Full record

ArticlePain and therapy2025

Evaluating Noninvasive Pulsed Electromagnetic Field Therapy for Joint and Soft Tissue Pain Management: A Prospective, Multi-center, Randomized Clinical Trial.

Joshua G Hackel, James M Paci, Sunny Gupta, David A Maravelas, Taylor J North, Adelina Paunescu

Registry-linked trialAbstract read
In one paragraph

Article in Pain and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05244187 (Prospective, Multi-Center, Randomized Study to Evaluate the OrthoCor Active System for Pain Relief), which is not on this map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05244187 nacompletednot on this map

Prospective, Multi-Center, Randomized Study to Evaluate the OrthoCor Active System for Pain Relief

TypeinterventionalSponsorCaerus CorporationRan2022 to 2023Enrolled120ConditionsPainArmsOrthoCor Active System
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joshua G HackelThe Andrews Institute for Orthopaedics and Sports Medicine, Pensacola, FL, USA. josh@hackelmd.com.ORCID http://orcid.org/0009-0006-4851-0431
James M PaciThe Orlin & Cohen Orthopedic Group at Northwell, Smithtown, NY, USA.
Sunny GuptaRothman Orthopaedic Institute, Marlton, NJ, USA.
David A Maravelas, Minneapolis, MN, USA.
Taylor J NorthThe Andrews Institute for Orthopaedics and Sports Medicine, Pensacola, FL, USA.
Adelina PaunescuMEDIcept Inc., Ashland, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionStrategies to reduce pharmacologic use for pain are needed. Pulsed electromagnetic field (PEMF) therapy is a noninvasive, nonpharmacologic treatment for pain that modifies nitric oxide signaling to improve healing. This study examined whether PEMF decreased pain and pharmacologic use vs. standard-of-care (SOC) treatment for joint and soft tissue pain.

methodsThis prospective, randomized controlled trial enrolled 120 patients presenting with joint or soft tissue pain at five orthopedic clinic sites. The PEMF group self-administered daily therapy from a commercially available device and the SOC group received standard treatment daily as prescribed by the clinician. Patients recorded their pain level, pharmacologic usage, and adverse events daily for 14 days. After 14 days, patients in the SOC group were given the option to crossover to PEMF therapy and continue for 16 days. The study was overseen by an independent clinical research organization. It was hypothesized that PEMF would be superior to SOC for pain management.

resultsPEMF treatment provided significant analgesic benefits compared to SOC. Complete data was collected for 91 patients, 48 from the PEMF group and 43 from the SOC group. The least squares mean pain score change from baseline was - 1.8 (a 36% reduction) for the PEMF group, significantly surpassing - 0.46 (a 10% reduction) for the SOC group (p < 0.0001). Pharmacologic usage decreased from 40 to 18% for the PEMF group (a 55% reduction), while the SOC group decreased from 40 to 35% (a 12% reduction). In the crossover subgroup, patients experienced an additional 18% decrease in pain score and 63% decrease in pharmacologic use after switching from SOC to PEMF treatment.

conclusionsPEMF was significantly more effective than SOC at managing pain and reducing pharmacologic use. PEMF therapy should be considered for noninvasive, nonpharmacologic management of joint and soft tissue pain.

trial registrationClinicalTrials.gov ID NCT05244187.

Indexed as

Bioelectronic therapyJoint painNitric oxideOsteoarthritis pain managementPain medicationPEMFPulsed electromagnetic fieldSoft tissue injury

Identifiers

PMID39928254
PMCPMC11914662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.